STI
46
-3
DHI
52
2
AMG
52
3
ADM
40
-4
ACN
38
-2
BSX
71
2
NEM
52
2
GPS
57
-3
RSG
68
-2
PYPL
33
2
DHR
56
5
LOW
59
-2
ZION
57
2
WMT
62
-5
MCHP
62
3
AKAM
45
-2
FSLR
70
-3
NDAQ
46
-3
MOS
36
4
MRK
53
-2
STI
46
-3
DHI
52
2
AMG
52
3
ADM
40
-4
ACN
38
-2
BSX
71
2
NEM
52
2
GPS
57
-3
RSG
68
-2
PYPL
33
2
DHR
56
5
LOW
59
-2
ZION
57
2
WMT
62
-5
MCHP
62
3
AKAM
45
-2
FSLR
70
-3
NDAQ
46
-3
MOS
36
4
MRK
53
-2
Financhill
Back

Ono Pharmaceutical Quote, Financials, Valuation and Earnings

Sell
21

OPHLF
Ono Pharmaceutical

Last Price:
14.75
Seasonality Move:
1.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Ono Pharmaceutical Price Quote

$14.75

Ono Pharmaceutical Key Stats

Sell
21
Ono Pharmaceutical (OPHLF) is a Sell
Day range:
$14.75 - $14.75
52-week range:
$14.47 - $19.89
Dividend yield:
3.61%
P/E ratio:
7.98
P/S ratio:
2.03
P/B ratio:
1.32%
Volume:
0
Avg. volume:
757
1-year change:
-27.29%
Market cap:
$6.9B
Revenue:
$3.5B
EPS:
$1.85

How Much Does Ono Pharmaceutical Make?

Is Ono Pharmaceutical Growing As A Company?

  • What Is Ono Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.07%
  • What Is Ono Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.04%

Ono Pharmaceutical Stock Price Performance

What Is Ono Pharmaceutical 52-Week High & Low?

Ono Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Ono Pharmaceutical?

Is Ono Pharmaceutical Cash Flow Positive?

  • What Is OPHLF Cash Flow From Operations?
    Cash flow from operations (TTM) is $766.9M
  • What Is Ono Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$622.6M
  • What Is Ono Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $333.2M

Ono Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    OPHLF return on invested capital is 16.43%
  • What Is Ono Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 14.34%
  • What Is OPHLF Return On Equity?
    ROE is a measure of profitability and is 16.43%

Ono Pharmaceutical Earnings Date & Stock Price

Ono Pharmaceutical Competitors

Ono Pharmaceutical Dividend Yield

Ono Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: -4.38% 0%
Revenue: -7.22% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many OPHLF shares are owned by institutional investors?
    125M OPHLF shares are owned by institutional investors
  • How many OPHLF shares are owned by insiders?
    0 OPHLF shares are owned by insiders